Spectrum Pharmaceuticals' P2P Acquisition

Spectrum Pharmaceuticals raised a round of funding on June 24, 2017. Investors include Repligen.

Spectrum Pharmaceuticals is a Healthcare/Biotechnology company. It develops oncology/hematology drugs.…

Articles about Spectrum Pharmaceuticals' P2P Acquisition: